| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.25M | 31.96M | 37.84M | 54.41M | 96.82M |
| Gross Profit | 17.56M | 16.57M | 23.39M | 40.88M | 88.71M |
| EBITDA | 12.81M | 36.27M | -179.52M | -52.65M | 87.01M |
| Net Income | 5.67M | 27.95M | -189.81M | -51.75M | 88.89M |
Balance Sheet | |||||
| Total Assets | 625.56M | 624.91M | 657.87M | 872.86M | 1.14B |
| Cash, Cash Equivalents and Short-Term Investments | 32.96M | 71.33M | 28.63M | 41.43M | 24.83M |
| Total Debt | 175.27M | 175.54M | 231.91M | 232.95M | 403.56M |
| Total Liabilities | 200.20M | 198.82M | 256.79M | 264.18M | 448.09M |
| Stockholders Equity | 425.36M | 426.09M | 401.07M | 608.67M | 687.04M |
Cash Flow | |||||
| Free Cash Flow | 250.00K | 1.10M | 11.66M | 219.00K | 2.96M |
| Operating Cash Flow | 293.00K | 1.44M | 12.27M | 767.00K | 3.03M |
| Investing Cash Flow | -36.57M | 105.98M | -20.70M | 192.25M | -174.37M |
| Financing Cash Flow | -7.26M | -59.55M | -19.53M | -185.58M | 45.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £350.91M | 17.24 | 5.35% | 5.88% | -0.42% | -13.35% | |
71 Outperform | £1.54B | 7.84 | 12.69% | 5.71% | 12.54% | 29.71% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | £1.21B | 9.49 | 6.53% | 3.62% | -23.35% | 20.53% | |
61 Neutral | £49.32M | 11.68 | 3.61% | 3.92% | -4.65% | -36.18% | |
56 Neutral | £153.35M | -27.70 | -2.38% | ― | ― | ― | |
51 Neutral | £230.04M | 41.25 | 1.34% | 2.71% | 4.03% | -79.67% |